Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | PAM | P19021 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 3/20 | 0.43 |
| ▸ | CES1 | P23141 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 4/20 | 0.42 |
| ▸ | PPARD | Q03181 | 4/20 | 0.42 |
| ▸ | PPARA | Q07869 | 4/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | TLR2 | O60603 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL556133 | 1.00 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL11747332 | 1.00 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL556542 | 0.98 | DGKA (0.48) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL556496 | 0.98 | DGKA (0.48) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL557016 | 0.96 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL557871 | 0.96 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL556453 | 0.96 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL557169 | 0.96 | DGKA (0.50) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL1083409 | 0.95 | DGKA (0.48) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL1083084 | 0.95 | DGKA (0.48) | DGKALMNAPAMMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-63196544-A | — | — | None | — | — | JP | disclosed |
| CN-113355002-B | Coating composition and method for forming multilayer coating film | 关西涂料株式会社 | 2024-01-30 | — | — | CN | disclosed |
| CN-117255838-A | Water-based paint composition for automobile exterior trim | 关西涂料株式会社 | 2023-12-19 | — | — | CN | disclosed |
| CN-108067410-B | Method for forming multilayer coating film | 关西涂料株式会社 | 2021-03-16 | — | — | CN | disclosed |
| EP-3577171-B1 | AQUEOUS SYSTEM FOR FORMING A COATING ON A SUBSTRATE | BASF SE (DE) | 2020-11-18 | — | — | EP | disclosed |
| US-10815383-B2 | Pigmented primer composition for forming an n-acyl urea coating | BASF SE (DE) | 2020-10-27 | — | — | US | disclosed |
| EP-3328945-B1 | PIGMENTED PRIMER COMPOSITION FOR FORMING AN N-ACYL UREA COATING | BASF SE (DE) | 2019-10-30 | — | — | EP | disclosed |
| US-10457767-B2 | Method of preparing a polycarbodiimide polymer and polycarbodiimide polymer prepared thereby | BASF SE (DE) | 2019-10-29 | — | — | US | disclosed |
| US-10435499-B2 | Solvent-borne system for forming an n-acyl urea coating | BASF SE (DE) | 2019-10-08 | — | — | US | disclosed |
| EP-3083745-B1 | POLYURETHANEUREAS OR POLYUREAS | COVESTRO LLC (US) | 2019-09-11 | — | — | EP | disclosed |
| US-6120699-A | CONVERTING A PORTION OF THE 4,4'-MDI INTO A POSITIVE AMOUNT OF A CARBODIIMIDE, THE CARBODIIMIDE SUBSEQUENTLY BEING CONVERTED INTO A POSITIVE AMOUNT OF A URETONIMINE IN THE PRESENCE OF EXCESS 4,4'-MDI | BASF CORPORATION (US) | 2000-09-19 | — | — | US | disclosed |
| EP-0989116-A1 | Storage stable methylene bis(phenylisocyanate) compositions | Basf Corporation (US) | 2000-03-29 | — | — | EP | disclosed |
| JP-S63196544-A | PRODUCTION OF FLUORINATED ALKYL (METH)ACRYLATES | OSAKA YUKI KAGAKU KOGYO KK | 1988-08-15 | — | — | JP | disclosed |
| US-4424288-A | Carbodiimide-modified polymethylene polyphenylene polyisocyanates for use in the preparation of polyisocyanurate-polyurethane foams | BASF WYANDOTTE CORPORATION (US) | 1984-01-03 | — | — | US | disclosed |
| US-4404352-A | ORGANOTIN COMPOUNDS AS CATALYST AND AMINES TO GIVE CURED COATINGS WITH PARTIALLY BLOCKED ISOCYANATES | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1983-09-13 | — | — | US | disclosed |
| EP-0073835-A1 | PROCESS FOR PRODUCING POLYURETHANE POLYMER | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1983-03-16 | — | — | EP | disclosed |
| US-4284730-A | Liquid carbodiimide- and uretonimine-isocyanurate-containing polyisocyanate compositions and microcellular foams made therefrom | BASF WYANDOTTE CORPORATION (US) | 1981-08-18 | — | — | US | disclosed |
| US-4228095-A | Process for the preparation of liquid carbodiimide-modified organic polyisocyanates employing organotin catalysts | BASF WYANDOTTE CORPORATION (US) | 1980-10-14 | — | — | US | disclosed |
| US-4038304-A | URETHANE PREPOLYMER | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1977-07-26 | — | — | US | disclosed |
| US-3989790-A | Method for preparing silicone rubber molds | SWS SILICONES CORPORATION (US) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10457767-B2 | Method of preparing a polycarbodiimide polymer and polycarbodiimide polymer prepared thereby | PAICS, PBRM1, PARG | DGKA 1336/4885LMNA 2029/4885PAM 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.